The latest closing stock price for Apogee Therapeutics as of March 28, 2025 is 39.72.
An investor who bought $1,000 worth of Apogee Therapeutics stock at the IPO in 2023 would have $871 today, roughly 1 times their original investment - a 36.78% compound annual growth rate over 2 years.
The all-time high Apogee Therapeutics stock closing price was 69.80 on March 13, 2024.
The Apogee Therapeutics 52-week high stock price is 68.21, which is 71.7% above the current share price.
The Apogee Therapeutics 52-week low stock price is 29.10, which is 26.7% below the current share price.
The average Apogee Therapeutics stock price for the last 52 weeks is 46.68.
An investor who bought $1,000 worth of Apogee Therapeutics stock at the IPO in 2023 would have $871 today, roughly 1 times their original investment - a 36.78% compound annual growth rate over 2 years.
The all-time high Apogee Therapeutics stock closing price was 69.80 on March 13, 2024.
The Apogee Therapeutics 52-week high stock price is 68.21, which is 71.7% above the current share price.
The Apogee Therapeutics 52-week low stock price is 29.10, which is 26.7% below the current share price.
The average Apogee Therapeutics stock price for the last 52 weeks is 46.68.